POST Online Media Lite Edition



 

Sirius Genomics: Chris Wagner new president and CEO

Staff writer |
Vancouver, BC, Canada - December 10, 2009, Vancouver, BC, Canada - Sirius Genomics, a developer of pharmacogenomic diagnostics, announced that Chris Wagner has been appointed president and chief executive officer.

Article continues below





Mr. Wagner has mora than 17 years of experience in marketing, sales and business development. Since 2007, Mr. Wagner was Vice President of Business Development at Sirius Genomics. Previously, Mr. Wagner was with Aspreva Pharmaceuticals as the Vice President of Marketing and Vice President of Business Development. Prior to Aspreva, Mr. Wagner was with Eli Lilly as an international service employee working in Europe, North America and Asia with positions based in Toronto, Indianapolis and Boston. Mr. Wagner holds a BSc in Organic Chemistry from the University of British Colum

 LATEST MOVES FROM British Columbia 

Pacific Imperial Mines appoints Richard Gosse as director
Orea Mining director Laurent Mathiot resigned
International Montoro Resources appoints Mark Luchinski to board
Dimension Five Technologies appoints Patrick Butler as director
East Asia Minerals appoints Karen Dyczkowski as CFO

What to read next

Solarvest Bioenergy: Richard Wagner and Philip Ranck to leave
Bruker Corporation: Charles F. Wagner, Jr. new EVP and CIO
Leon Wagner joins Lighting Science Group